A cross-sectional comparative study evaluating male sexual health found no statistically significant differences in erectile or ejaculatory function between men with a history of coronary revascularization and men without known coronary artery disease. Published in BMC Urology by researchers Ozan Oğuz and Çağrı Öktem, the investigation analyzed clinical survey measures across both cohorts to determine whether surgical or catheter-based coronary interventions relate to post-procedure sexual health outcomes.
Erectile dysfunction is known to be closely associated with cardiovascular disease, yet the specific relationship between previous coronary revascularization and diverse aspects of male sexual function has remained unclear. To address this question, the researchers conducted a comparative assessment focusing on both erectile performance and multiple parameters of ejaculatory performance between patients who had undergone revascularization procedures and individuals presenting without known coronary artery disease.
The cross-sectional investigation evaluated a total of 135 men between July 2026 and October 2026. The study cohort was divided into two distinct groups: a control cohort consisting of 69 men without known coronary artery disease, and an intervention cohort comprising 66 men with a documented history of coronary revascularization via percutaneous coronary intervention or coronary artery bypass grafting.
The investigators utilized standardized clinical diagnostic instruments to evaluate participant sexual health. Erectile function was quantified using the Sexual Health Inventory for Men (SHIM), while premature ejaculation symptoms were measured through the Premature Ejaculation Diagnostic Tool (PEDT). Ejaculatory function was further assessed using the Male Sexual Health Questionnaire-Ejaculatory Dysfunction (MSHQ-EjD), and participants additionally provided self-reported ejaculation latency measurements.
Assessment of erectile capacity demonstrated identical median SHIM scores of 15 in both the control cohort and the revascularization group, yielding no statistically significant difference (p = 0.416). Furthermore, screening positivity for erectile dysfunction was identified in 81.2% of men in the control group and 86.4% of men in the coronary revascularization group, a comparison that also showed no statistically significant divergence between cohorts (p = 0.488).
Evaluations of ejaculatory performance similarly revealed no statistically significant differences across all evaluated metrics. Scores on the Premature Ejaculation Diagnostic Tool showed comparable distributions between cohorts (p = 0.595), self-reported ejaculation latency did not differ significantly between groups (p = 0.494), and domain scores on the Male Sexual Health Questionnaire-Ejaculatory Dysfunction demonstrated no statistically significant differences (all p > 0.05).
Clinical profiling revealed that participants in the coronary revascularization cohort exhibited higher baseline frequencies of diabetes mellitus, hypertension, and smoking compared to controls. To account for these potential confounding variables, the researchers performed multivariable linear regression to assess the independent relationship between coronary revascularization history and SHIM scores. After statistical adjustment for potential confounders, previous coronary revascularization remained not significantly associated with SHIM scores (β = -0.91; 95% CI, -3.01 to 1.19; p = 0.393).
The multivariable regression model identified patient age as an independent factor influencing erectile performance. Specifically, increasing age was significantly and independently associated with lower SHIM scores across the study cohort (β = -0.18; p = 0.012), indicating that older age correlated with reduced erectile function regardless of revascularization status.
The study authors concluded that while no statistically significant differences in erectile or ejaculatory function were identified between men with prior coronary revascularization and those without known coronary artery disease in this sample, the lack of statistical significance must not be interpreted as evidence of clinical equivalence between the two groups. Emphasizing the cross-sectional nature of the evaluation and the independent impact of aging, the authors noted that larger prospective studies remain necessary to further clarify these relationships.
Subject of Research: Male erectile and ejaculatory function following coronary revascularization
Article Title: Erectile and ejaculatory function in men with and without a history of coronary revascularization: a cross-sectional comparative study
Article References: Oğuz, O., & Öktem, Ç. (2026). Erectile and ejaculatory function in men with and without a history of coronary revascularization: a cross-sectional comparative study. BMC Urology. https://doi.org/10.1186/s12894-026-02471-0
Image Credits: AI Generated
DOI: 10.1186/s12894-026-02471-0
Keywords: coronary revascularization, erectile dysfunction, ejaculatory function, percutaneous coronary intervention, coronary artery bypass grafting, coronary artery disease, Sexual Health Inventory for Men, Premature Ejaculation Diagnostic Tool, MSHQ-EjD, ejaculation latency, cardiovascular disease, multivariable linear regression, cross-sectional study, male sexual health, aging and erectile function, diabetes mellitus, hypertension
News Source: Ophelia Keating. (November 16, 2026). Coronary Revascularization Shows No Significant Link to Erectile or Ejaculatory Function. Scienmag.



